Search Legislation

Regulation (EU) 2016/793 of the European Parliament and of the CouncilShow full title

Regulation (EU) 2016/793 of the European Parliament and of the Council of 11 May 2016 to avoid trade diversion into the European Union of certain key medicines (codification)

 Help about what version

What Version

Close

This is a legislation item that originated from the EU

After exit day there will be three versions of this legislation to consult for different purposes. The legislation.gov.uk version is the version that applies in the UK. The EU Version currently on EUR-lex is the version that currently applies in the EU i.e you may need this if you operate a business in the EU.

The web archive version is the official version of this legislation item as it stood on exit day before being published to legislation.gov.uk and any subsequent UK changes and effects applied. The web archive also captured associated case law and other language formats from EUR-Lex.

Changes to legislation:

There are outstanding changes not yet made to Regulation (EU) 2016/793 of the European Parliament and of the Council. Those changes will be listed when you open the content using the Table of Contents below. Any changes that have already been made to the legislation appear in the content and are referenced with annotations. Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. Changes and effects are recorded by our editorial team in lists which can be found in the ‘Changes to Legislation’ area. Where those effects have yet to be applied to the text of the legislation by the editorial team they are also listed alongside the affected provisions when you open the content using the Table of Contents below.

View outstanding changes

Changes and effects yet to be applied to :

Changes and effects yet to be applied to the whole legislation item and associated provisions

  1. Introductory Text

  2. Article 1.(1) This Regulation lays down: (a) the criteria for establishing...

  3. Article 2.(1) The importation into the Union of tiered-priced products for...

  4. Article 3.The tiered price referred to in Article 4(2)(b) shall, at...

  5. Article 4.(1) In order for products to benefit from this Regulation,...

  6. Article 5.(1) The power to adopt delegated acts is conferred on...

  7. Article 6.(1) Delegated acts adopted under this Article shall enter into...

  8. Article 7.A product approved as a tiered-priced product and listed in...

  9. Article 8.A permanent logo, as set out in Annex V, shall...

  10. Article 9.(1) Where there is reason to suspect that, contrary to...

  11. Article 10.(1) If products suspended for release or detained by customs...

  12. Article 11.This Regulation shall not apply to goods of a non-commercial...

  13. Article 12.(1) The Commission shall monitor on an annual basis the...

  14. Article 13.(1) The application of this Regulation shall in no circumstances...

  15. Article 14.Regulation (EC) No 953/2003 is repealed. References to the repealed...

  16. Article 15.This Regulation shall enter into force on the twentieth day...

  17. Signature

    1. ANNEX I

      LIST OF TIERED-PRICED PRODUCTS

    2. ANNEX II

      COUNTRIES OF DESTINATION

      1. Afghanistan

      2. Angola

      3. Armenia

      4. Azerbaijan

      5. Bangladesh

      6. Benin

      7. Bhutan

      8. Botswana

      9. Burkina Faso

      10. Burundi

      11. Cambodia

      12. Cameroon

      13. Cape Verde

      14. Central African Republic

      15. Chad

      16. China

      17. Comoros

      18. Congo

      19. Côte d'Ivoire

      20. Democratic Republic of the Congo

      21. Djibouti

      22. Equatorial Guinea

      23. Eritrea

      24. Ethiopia

      25. Gambia

      26. Ghana

      27. Guinea

      28. Guinea-Bissau

      29. Haiti

      30. Honduras

      31. India

      32. Indonesia

      33. Kenya

      34. Kiribati

      35. Kyrgyzstan

      36. Laos

      37. Lesotho

      38. Liberia

      39. Madagascar

      40. Malawi

      41. Maldives

      42. Mali

      43. Mauritania

      44. Moldova

      45. Mongolia

      46. Mozambique

      47. Myanmar/Burma

      48. Namibia

      49. Nepal

      50. Nicaragua

      51. Niger

      52. Nigeria

      53. North Korea

      54. Pakistan

      55. Rwanda

      56. Samoa

      57. São Tomé and Príncipe

      58. Senegal

      59. Sierra Leone

      60. Solomon Islands

      61. Somalia

      62. South Africa

      63. Sudan

      64. Swaziland

      65. Tajikistan

      66. Tanzania

      67. Timor-Leste

      68. Togo

      69. Turkmenistan

      70. Tuvalu

      71. Uganda

      72. Vanuatu

      73. Vietnam

      74. Yemen

      75. Zambia

      76. Zimbabwe

    3. ANNEX III

      PERCENTAGES REFERRED TO IN ARTICLE 3

      1. Percentage referred to in Article 3(a): 25 %

      2. Percentage referred to in Article 3(b): 15 %

    4. ANNEX IV

      SCOPE OF DISEASES

      1. HIV/AIDS, malaria, tuberculosis and related opportunistic diseases

    5. ANNEX V

      LOGO

      1. The winged staff of Aesculapius with a coiled serpent, in...

    6. ANNEX VI

      REPEALED REGULATION WITH LIST OF ITS SUCCESSIVE AMENDMENTS

    7. ANNEX VII

      CORRELATION TABLE

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the EU Official Journal
  • lists of changes made by and/or affecting this legislation item
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Timeline of Changes

This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.

The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.

For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources